Octax Microscience GmbH

Allgemeine Informationen

Vitrolife was established in Sweden in 1994 when the field of assisted reproduction was still young.

The possibility to help people become parents through assisted reproduction became a reality in the 1960s, following the development of a method for fertilising eggs outside the body. The birth of Louise Brown in 1978 – the first baby born as a result of in vitro
fertilisation (IVF) – gave new hope to men and women suffering from infertility.

As IVF techniques developed, the importance of individual components on IVF success began to be understood. The founders of Vitrolife realised the value of using culture media with consistent and repeatable performance; the manufacturing and delivering of LOTto-LOT
consistency they developed is still significant for Vitrolife today.

Through well-executed product development, consistent quality controls and the acquisition of other innovative IVF companies, Vitrolife has grown with the market globally. As a result, Vitrolife provides an unbroken chain of quality products, securing results at every
step of IVF treatment. Only Vitrolife can guarantee every link in this chain.

Our commitment to increase pregnancy rates has never been more dedicated. Together with equally devoted clinics, we are improving IVF success and fulfilling more couples’ greatest dream. We are very proud to be a part of making this happen.